View
Hello Astrognat, this is an interesting one! I will investigate this now and see if I can get it going
BTG pricing does not seem to work and the forum does not seem linked to LSE / iii
Thank you so much for your rapid and extremely helpful reply.
You mentioned, in passing, an AGM presentation, I have been looking for presentations and have not found any. Is there anywhere I can get it?
Best regards Richard
Richard,
You asked where I got the following from:
a.)"Professor Durrant has discovered special modified versions of over 100 cancer and pathogen epitopes."
and
b.)"It is hoped that for every natural epitope there is a Moditope, enough to allow T Cells to home in on every known cancer and virus."
a.) was announced at the company's AGM on 7th November 2012.
and
b.) is an extrapolation of the science itself. At the moment Scancell uses natural cancer epitopes in its ImmunoBody cancer vaccines and other companies using ImmunoBody under licence to make vaccines to combat infectious diseases, such as Immbio, use natural viral epitopes. It is hoped that Scancell and other companies like Immbio will be able to incorporate the more powerful Moditope epitopes in their vaccines instead. And that of course for every natural epitope in use a more effective Moditope equivalent can be discovered and patented.
You queried further:
"It appears to me that Scancell are not patenting the individual epitopes at the moment. Am I wrong?"
To answer this (aside from referring to the AGM presentation) here are some extracts from Scancell's announcement to market on 15th August 2012:
"Scancell has identified and patented a series of modified epitopes."
"Not only do these unique epitopes stimulate a CD4 killer T cell response, we have also shown in tests that cancer patients can produce an immune response to these epitopes. The Moditope epitopes can be used to develop both DNA and peptide vaccines and could become an important component of many therapeutic vaccines in the future, both under development at Scancell and other companies.â€
Source:
[link]
Hi Lady Bio,
Thank you for your very interesting contributions.
You mention two particular points which I have been unable to find elsewhere. I would love to know where you got them from!
a. "Professor Durrant has discovered special modified versions of over 100 cancer and pathogen epitopes".
b. " It is hoped that for every natural epitope there is a Moditope, enough to allow T Cells to home in on every known cancer and virus."
It appears to me that Scancell are not patenting the individual epitopes at the moment. Am I wrong?
Richard
is this share very cheap ? i guess it is a Buy. i bought a few years back at about £4 could have a long wait.
I think this firm is now at the stage where it either the SP recovers or the company is taken over. Looking again at the balance sheets seems like 2013 will be a turning point back to profitablity so this current value seems very strange.
I think the SP is not helped in anyway by the company Chairman failing to update on the independent consultants report on the future strategic direction of CFC.
It seeems there are two tiers of investor those in the 'know' and those who are outsiders and kept in the dark.
I think the lack of enagagement with shareholders seems to be whats holding back this firm.
Lady Bio many thanks for your response. let's all hope you're right!